Search
for

    GlossaryNonsteroidal Antiandrogens (Nonsteroidal Androgen Receptor Antagonists)

    medications that block male hormones without activating their receptors

    Nonsteroidal Antiandrogens (NSAA) are medications that block the action of androgens (male hormones like testosterone) by binding to androgen receptors without activating them. They are commonly used in the treatment of conditions like prostate cancer and androgenic alopecia (hair loss) by preventing androgens from stimulating the growth of cancer cells or hair follicles.

    Related Terms

    Products matching "nonsteroidal androgen receptor antagonists"

    Tracking 2 products like 259 Pyrilutamide (KX-826) Solution – 30ml 5mg/ml and 262 Pyrilutamide KX-826 Powder – 500mg from by companies like Anageninc. View all 2 products »

    Learn

    4 / 4 results

      learn Pyrilutamide

      highly targeted anti-androgen that might have minimal systemic effects

      learn Bicalutamide

      a nonsteroidal anti-androgen, most commonly used orally for women

      learn Fluridil

      a topical anti-androgen with less systemic involvement

    Research

    5 / 1000+ results

    Community Join

    5 / 49 results

      community Is this broscience? From More Plates, More Dates

      in Research/Science  21 upvotes 9 months ago
      The conversation discusses whether finasteride's reduction of DHT and increase in scalp testosterone contribute to hair follicle miniaturization. Some participants argue testosterone does not cause miniaturization, while others suggest that even with reduced DHT, other androgens like testosterone may still contribute to hair loss.

      community Binding affinity of pyrilutamide!

      in Update  167 upvotes 2 years ago
      Pyrilutamide, a nonsteroidal antiandrogen drug under development for the potential treatment of androgenic alopecia. The conversation discusses its binding affinity to the androgen receptor and the timeline for possible availability after trials are completed in the United States and China.